Paradigm Peptides / Canlab Research

This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Sources for this entry are named inline below and numbered in full on the parent archive page.

Paradigm Peptides ceased operations; Canlab Research was suspended by Health Canada. Both are documented in retrospective peptide-industry analyses but predate our primary-source archive, listed here for completeness rather than as detailed case studies.

← Back to the full Vendor Graveyard

Every verified shutdown, exit scam, and FDA action, 2018–2026, in one dated archive.